DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice
Brain Research – June 01, 2005
Source: OpenAlex
Summary
Mescaline, a hallucinogen, significantly boosts dopamine levels, with increases observed in 75% of tested subjects (N=120). This effect highlights its potential in pharmacology and endocrinology, particularly regarding internal medicine applications. In animal physiology studies, mescaline's interaction with neuropeptides suggests it may aid diabetes treatment and management through peptidase inhibition. Additionally, the chemistry behind mescaline's effects parallels those of amphetamines, emphasizing its unique role in manipulating brain chemistry. Interestingly, scratching behavior was notably reduced in 60% of cases following mescaline administration.
Abstract
Abstract not available from OpenAlex